sales@businessmarketinsights.com     UK: +442081254005
   

Asia Pacific Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare)

Code: TIPRE00016308 | Pages: 117 | Industry: Medical Device | Date: Nov 2020
Covid

Market Introduction

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

Market Overview and Dynamics

The Asia Pacific Neuromodulation market is projected to reach US$ 3,518.34 million by 2027 from US$ 1,559.89 million in 2019; it is estimated to grow with a CAGR of 11.0% from 2020 to 2027. The growth of the Asia Pacific neuromodulation market is attributed to the increasing incidence of neurological disorders, growing developments in neuromodulation technology. However, high cost of neuromodulation devices the growth of market in this region. leading to restraining the growth of the market.

Key Market Segments

Based on technology, the Asia Pacific neuromodulation market is segmented into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment held a larger share of the market. External (non-invasive) neuromodulation is expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to while preparing the Asia Pacific neuromodulation market report are World Health Organization, Ministry of Health & Prevention, Parkinson’s Disease & Movement Disorder Society (PDMDS), and Garvan Institute, and Ministry of Health and Family Welfare.

Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim.

Reasons to buy the report

  • To understand the Asia Pacific neuromodulation market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the Asia Pacific neuromodulation market
  • To efficiently plan M&A and partnership deals in the Asia Pacific neuromodulation market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Asia Pacific neuromodulation market
  • To obtain market revenue forecast from 2019 to 2027 in various segments of the Asia Pacific neuromodulation market

ASIA PACIFIC NEUROMODULATION MARKET SEGMENTATION

By Technology

  • External (Non-Invasive) Neuromodulation
    • Respiratory Electrical Stimulation
    • Transcutaneous Electrical Nerve Stimulation
    • Transcranial Magnetic Stimulation
  • Internal Neuromodulation
    • Deep Brain Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
    • Spinal Cord Stimulation
    • Vagus Nerve Stimulation

By Application

  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Obsessive-Compulsive Disorder
  • Migraine

By End User

  • Hospitals
  • Clinics
  • Home Healthcare

By Country

  • Japan
  • China
  • India
  • South Korea
  • Australia

Company Profiles

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Asia-Pacific Neuromodulation Market – By Technology

1.3.2        Asia-Pacific Neuromodulation Market – By Application

1.3.3        Asia-Pacific  Neuromodulation Market – By End User

1.3.4        Asia-Pacific Neuromodulation Market – By Country

2.             Neuromodulation Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Asia-Pacific Neuromodulation– Market Landscape

4.1       Overview

4.2       PEST Analysis

Expert Opinions

5.             Neuromodulation Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Increasing Incidence of Neurological Disorders

5.1.2        Growing Developments in Neuromodulation Technology

5.2       Market Restraints

5.2.1        High Cost of Neuromodulation Devices

5.3       Market Opportunities

5.3.1        Rising Demand for Neurostimulation Devices to Treat Chronic Pain

5.4       Future Trends

5.4.1        Technological Advancements

5.5       Impact Analysis

6.             Neuromodulation Market Analysis – By Technology

6.1       Overview

6.2       Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

6.3       External Neuromodulation

6.3.1        Overview

6.3.2        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.3.3        Respiratory Electrical Stimulation (RES)

6.3.3.1      Overview

6.3.3.2      Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.3.4        Transcutaneous Electrical Nerve Stimulation (TENS)

6.3.4.1      Overview

6.3.4.2      Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.3.5        Transcranial Magnetic Stimulation (TMS)

6.3.5.1      Overview

6.3.5.2      Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4       Internal Neuromodulation

6.4.1        Overview

6.4.2        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.3        Deep Brain Stimulation (DBS)

6.4.3.1      Overview

6.4.3.2      Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.4        Sacral Nerve Stimulation (DBS)

6.4.4.1      Overview

6.4.4.2      Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.5        Gastric Electric Stimulation (GES)

6.4.5.1      Overview

6.4.5.2      Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.6        Spinal Cord Stimulation (SCS)

6.4.6.1      Overview

6.4.6.2      Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.7        Vagus Nerve Stimulation (VNS)

6.4.7.1      Overview

6.4.7.2      Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.             Neuromodulation Market Analysis – By Application

7.1       Overview

7.2       Neuromodulation Market Share, by Application, 2019 and 2027 (%)

7.3       Chronic Pain Management

7.3.1        Overview

7.3.2        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4       Failed Back Syndrome

7.4.1        Overview

7.4.2        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.5       Epilepsy

7.5.1        Overview

7.5.2        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.6       Tremor

7.6.1        Overview

7.6.2        Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.7       Incontinence

7.7.1        Overview

7.7.2        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.8       Depression

7.8.1        Overview

7.8.2        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.9       Dystonia

7.9.1        Overview

7.9.2        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.10    Gastroparesis

7.10.1     Overview

7.10.2     Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.11    Parkinson’s Disease

7.11.1     Overview

7.11.2     Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.12    Obsessive-Compulsive Disorder (OCD)

7.12.1     Overview

7.12.2     Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.13    Migraine

7.13.1     Overview

7.13.2     Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.             Neuromodulation Market Analysis – By End User

8.1       Overview

8.2       Neuromodulation Market Share, by End User, 2019 and 2027, (%)

8.3       Hospitals

8.3.1        Overview

8.3.2        Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Clinics

8.4.1        Overview

8.4.2        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Home Healthcare

8.5.1        Overview

8.5.2        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.             Neuromodulation Market Analysis and Forecasts To 2027 – Regional Analysis

9.1       Asia Pacific: Neuromodulation Market

9.1.1        Overview

9.1.2        Asia Pacific: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

9.1.3        Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.3.1      Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

9.1.3.2      Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.4        Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.5        Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.6        Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)

9.1.7        China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1      China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2      China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.1       China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2       China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.3      China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.7.4      China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.8        Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1      Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2      Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.1       Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2       Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3      Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.8.4      Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.9        India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1      India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2      India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.9.2.1       India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.9.2.2       India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.9.3      India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.9.4      India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.10     South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1    South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2    South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.10.2.1    South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

9.1.10.2.2    South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.10.3    South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.10.4    South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.11     Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.1    Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.2    Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.11.2.1    Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

9.1.11.2.2    Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.11.3    Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.11.4    Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.          Impact of COVID-19 Pandemic on Asia Pacific Neuromodulation Market

10.1    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.          Company Profiles

11.1    Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2    Boston Scientific Corporation

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3    Medtronic

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4    NeuroPace, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5    NeuroSigma, Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6    Nevro Corp.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7    Synapse Biomedical Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8    Soterix Medical Inc

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9    Integer Holdings Corporation

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10 Magstim

11.10.1   Key Facts

11.10.2   Business Description

11.10.3   Products and Services

11.10.4   Financial Overview

11.10.5   SWOT Analysis

11.10.6   Key Developments

12.          Appendix

12.1    Glossary of Terms


LIST OF TABLES

Table 1.             Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 2.             Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 3.             Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 7.             China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 13.          Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 17.          India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20.          India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 22.          South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 23.          South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 25.          South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 26.          Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 27.          Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 28.          Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29.          Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 30.          Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          Glossary of Terms, Neuromodulation Market

 


LIST OF FIGURES

Figure 1.           Neuromodulation Market Segmentation

Figure 2.           Asia-Pacific Neuromodulation Market – By Country

Figure 3.           Asia-Pacific Neuromodulation Market Overview

Figure 4.           Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia-Pacific Neuromodulation Market- Leading Country Markets (US$ Million)

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Neuromodulation Market Impact Analysis of Drivers and Restraint

Figure 9.           Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

Figure 10.        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027  (US$ Million)

Figure 14.        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Neuromodulation Market Share, by Application, 2019 and 2027 (%)

Figure 21.        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Neuromodulation Market Share, by End User, 2019 and 2027 (%)

Figure 33.        Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Asia Pacific: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 37.        Asia Pacific: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 38.        Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 39.        China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

The List of Companies - Asia Pacific Neuromodulation Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  10. Magstim
  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific neuromodulation market

 

  • Highlights key business priorities to assist companies in order to realign their business strategies

 

  • Highlights key findings and recommendations of crucial progressive industry trends in the Asia Pacific neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies

 

  • Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets

 

  • Scrutinizes in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it

 

  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

 


Related Tags Asia pacific Neuromodulation Market Asia pacific Neuromodulation Market Research Asia pacific Neuromodulation Market Insight Asia pacific Neuromodulation Market Trends Asia pacific Neuromodulation Market Forecast Asia pacific Neuromodulation Market Share Asia pacific Neuromodulation Market 2027 Asia pacific Neuromodulation Market Growth Asia pacific Neuromodulation Industry Sector Asia pacific Neuromodulation PDF Report Asia pacific Neuromodulation Analysis Asia pacific Neuromodulation Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000